Chimpanzee Adenovirus Vaccine Provides Multispecies Protection against Rift Valley Fever

A Monovalent Chimpanzee Adenovirus Ebola Vaccine Boosted with MVA

(2016) Katie Ewer et al.   NEW ENGLAND JOURNAL OF MEDICINE

Understanding Rift Valley fever: Contributions of animal models to disease characterization and control

(2015) Gema Lorenzo et al.   MOLECULAR IMMUNOLOGY

Ebola teaches tough lessons about rapid research

(2015) Erika Check Hayden   NATURE

Chimpanzee adenovirus– and MVA-vectored respiratory syncytial virus vaccine is safe and immunogenic in adults

(2015) Christopher A. Green et al.   Science Translational Medicine

One Health approach to Rift Valley fever vaccine development

(2014) Jeroen Kortekaas   ANTIVIRAL RESEARCH

A human vaccine strategy based on chimpanzee adenoviral and MVA vectors that primes, boosts, and sustains functional HCV-specific T cell memory

(2014) L. Swadling et al.   Science Translational Medicine

Development of a Rift Valley fever virus viremia challenge model in sheep and goats

(2014) Hana M. Weingartl et al.   VACCINE

A Glycoprotein Subunit Vaccine Elicits a Strong Rift Valley Fever Virus Neutralizing Antibody Response in Sheep

(2014) Bonto Faburay et al.   VECTOR-BORNE AND ZOONOTIC DISEASES

Clinical Assessment of a Novel Recombinant Simian Adenovirus ChAdOx1 as a Vectored Vaccine Expressing Conserved Influenza A Antigens

(2013) Richard D Antrobus et al.   MOLECULAR THERAPY

Vaccine-elicited Human T Cells Recognizing Conserved Protein Regions Inhibit HIV-1

(2013) Nicola Borthwick et al.   MOLECULAR THERAPY

Immunogenicity and efficacy of a chimpanzee adenovirus-vectored Rift Valley Fever vaccine in mice

(2013) George M Warimwe et al.   Virology Journal

Protective CD8+ T-cell immunity to human malaria induced by chimpanzee adenovirus-MVA immunisation

(2013) Katie J. Ewer et al.   Nature Communications

A Novel Chimpanzee Adenovirus Vector with Low Human Seroprevalence: Improved Systems for Vector Derivation and Comparative Immunogenicity

(2012) Matthew D. J. Dicks et al.   PLoS One

Vaccine Vectors Derived from a Large Collection of Simian Adenoviruses Induce Potent Cellular Immunity Across Multiple Species

(2012) S. Colloca et al.   Science Translational Medicine

Breaking the chain: Rift Valley fever virus control via livestock vaccination

(2012) Brian H Bird et al.   Current Opinion in Virology

Immunogenicity and safety of an inactivated Rift Valley fever vaccine in a 19-year study

(2011) Janice M. Rusnak et al.   VACCINE

Safety and efficacy of Rift Valley fever Smithburn and Clone 13 vaccines in calves

(2011) Beate von Teichman et al.   VACCINE

Rift Valley Fever Virus Epidemic in Kenya, 2006/2007: The Entomologic Investigations

(2010) Rosemary Sang et al.   AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE

Epidemiologic and Clinical Aspects of a Rift Valley Fever Outbreak in Humans in Tanzania, 2007

(2010) Mohamed Mohamed et al.   AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE

Evaluation of the efficacy and safety of the Rift Valley Fever Clone 13 vaccine in sheep

(2010) Baptiste Dungu et al.   VACCINE

Experimental Infection of Young Adult European Breed Sheep with Rift Valley Fever Virus Field Isolates

(2010) Nuria Busquets et al.   VECTOR-BORNE AND ZOONOTIC DISEASES

Prediction of a Rift Valley fever outbreak

(2009) Assaf Anyamba et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Global trends in emerging infectious diseases

(2008) Kate E. Jones et al.   NATURE